Anti-SARS-CoV-2 vaccination in people with multiple sclerosis: Lessons learnt a year inMaura Pugliatti, Thomas Berger, Laura Airas et al.|Frontiers in Immunology|2022Cited by 11
Generics, Biosimilars and Follow‐On Non‐Biologic Complex Drugs for Multiple Sclerosis: A Narrative Review of the Regulatory and Clinical Implications for European NeurologistsThomas Berger, Celia Oreja‐Guevara, Melinda Magyari et al.|European Journal of Neurology|2025Cited by 4